Oncology & Cancer

Organized screening for prostate cancer does more harm than good

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm ...

Oncology & Cancer

PSA screening tied to lower risk of prostate cancer mortality

Prostate-specific antigen (PSA) screening is associated with decreased risk of prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in JAMA Oncology.

page 16 from 33